PortfoliosLab logoPortfoliosLab logo
Issuer
Direxion
Inception Date
Sep 30, 2025
Region
North America (U.S.)
Leveraged
2x
Index Tracked
No Index (Active)
Domicile
US
Distribution Policy
Distributing
Asset Class
Equity
Assets Under Management
$3M

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

TBXU Performance Chart

Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) is down 6.2% since the beginning of the year. TBXU is currently trading at $29 per share.


Loading charts...

S&P 500 Index

Returns By Period


Direxion Daily Biotech Top 5 Bull 2X ETF

1D
-2.39%
1M
0.27%
YTD
-6.15%
6M
-7.27%
1Y
3Y*
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
0.00%
1M
-0.71%
YTD
8.39%
6M
8.57%
1Y
24.33%
3Y*
18.94%
5Y*
12.24%
10Y*
13.54%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TBXU Monthly Returns History

Based on dividend-adjusted daily data since Oct 1, 2025, TBXU's average daily return is +0.09%, while the average monthly return is +1.43%. At this rate, an investment would double in approximately 4.1 years.

Historically, 44% of months were positive and 56% were negative. The best month was Nov 2025 with a return of +17.4%, while the worst month was Mar 2026 at -12.6%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 4 months.

On a daily basis, TBXU closed higher 46% of trading days. The best single day was Jan 7, 2026 with a return of +6.5%, while the worst single day was Mar 5, 2026 at -5.9%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20266.87%8.46%-12.61%-5.84%-0.56%-1.05%-6.15%
20256.99%17.35%-6.73%17.10%

Benchmark Metrics

Direxion Daily Biotech Top 5 Bull 2X ETF has an annualized alpha of 5.62%, beta of 1.06, and R2 of 0.12 versus S&P 500 Index. Calculated based on daily prices since October 01, 2025.

  • This ETF participated in 150.34% of S&P 500 Index downside but only 129.07% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.12 means this ETF moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
5.62%
Beta
1.06
0.12
Upside Capture
129.07%
Downside Capture
150.34%

Expense Ratio

TBXU has a high expense ratio of 0.98%, indicating above-average management fees.


Return for Risk

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TBXUBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.35

Calmar ratioReturn relative to maximum drawdown

2.66

Martin ratioReturn relative to average drawdown

11.86

Dividends

Dividend History

Direxion Daily Biotech Top 5 Bull 2X ETF provided a 1.76% dividend yield over the last twelve months, with an annual payout of $0.51 per share.


1.33%$0.00$0.10$0.20$0.30$0.402025
Dividends
Dividend Yield
PeriodTTM2025
Dividend$0.51$0.41

Dividend yield

1.76%1.33%

Monthly Dividends

The table displays the monthly dividend distributions for Direxion Daily Biotech Top 5 Bull 2X ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.10$0.00$0.00$0.00$0.10
2025$0.41$0.41

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Direxion Daily Biotech Top 5 Bull 2X ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Direxion Daily Biotech Top 5 Bull 2X ETF was 26.53%, occurring on Jun 2, 2026. The portfolio has not yet recovered.

The current Direxion Daily Biotech Top 5 Bull 2X ETF drawdown is 21.28%.


Related event

Drawdown

Fall

Recovery

Underwater

2026 bear market2026
-26.53%Jun 2026
3mo 15d
4mo 5dFeb 2026 - now
2025 correction2025
-13.84%Dec 2025
5d1mo 18d
1mo 23dDec 2025 - Jan 2026
2026 pullback2026
-5.71%Feb 2026
1d3d
4dFeb 2026 - Feb 2026
2025 pullback2025
-4.18%Oct 2025
3d4d
7dOct 2025 - Oct 2025
2025 pullback2025
-4.06%Dec 2025
3d2d
5dNov 2025 - Dec 2025

Drawdown Indicators


TBXUBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-26.53%

-56.78%

+30.25%

Max Drawdown (1Y)

Largest decline over 1 year

-9.10%

Max Drawdown (3Y)

Largest decline over 3 years

-18.90%

Max Drawdown (5Y)

Largest decline over 5 years

-25.43%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-21.28%

-2.49%

-18.79%

Average Drawdown

Average peak-to-trough decline

-9.32%

-10.72%

+1.40%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.03%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Portfolio Analyzer

Build a portfolio with TBXU

Add Direxion Daily Biotech Top 5 Bull 2X ETF to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with TBXU